Stocks / NASDAQ / Relmada Therapeutics, Inc.

Relmada Therapeutics, Inc.

Our Opinion

Relmada Therapeutics, Inc. is on the Cruelty Free Investing use of animals list because they conduct pre-clinical studies of their drugs on animals to assess a product’s safety profile.

Supporting Evidence:

The company stated in the following report that they exploit animals for product testing.

“In May 2016, we announced the results of an in vivo study showing that administration of d-methadone results in antidepressant-like effects in a well-validated animal model of depression, known as the forced swim test (FST), providing preclinical support for its potential as a novel treatment of depression.” (Page 4) Read the full document

Company Description

Company Website: